← Evidence map

ReviewAnnals of translational medicine2017

MET/HGF pathway activation as a paradigm of resistance to targeted therapies.

Brian Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28164089